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Abstract
Previously, we reported human traumatic brain injury cases demonstrating acute to subacute microbleed appearance changes in
susceptibility-weighted imaging (SWI—magnetic resonance imaging [MRI]). This study aims to confirm and characterize such
temporal microbleed appearance alterations in an experimental model. To elicit microbleed formation, brains of male Sprague
Dawley rats were pierced in a depth of 4 mm, in a parasagittal position bilaterally using 159lm and 474lm needles, without the
injection of autologous blood or any agent. Rats underwent 4.7 T MRI immediately, then at multiple time points until 125 h.
Volumes of hypointensities consistent with microbleeds in SWI were measured using an intensity threshold-based approach.
Microbleed volumes across time points were compared using repeated measures analysis of variance. Microbleeds were
assessed by Prussian blue histology at different time points. Hypointensity volumes referring to microbleeds were significantly
decreased (corrected p< 0.05) at 24 h compared with the immediate or the 125 h time points. By visual inspection, microbleeds
were similarly detectable at the immediate and 125 h imaging but were decreased in extent or completely absent at 24 h or 48 h.
Histology confirmed the presence of microbleeds at all time points and in all animals. This study confirmed a general temporary
reduction in visibility of microbleeds in the acute phase in SWI. Such short-term appearance dynamics of microbleeds should be
considered when using SWI as a diagnostic tool for microbleeds in traumatic brain injury and various diseases.
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Introduction
The term cerebral microbleed (or microhemorrhage) refersto small extravascular collections of blood or blood products
in the brain that are visible as signal voids in magnetic suscepti-
bility sensitive magnetic resonance imaging (MRI) techniques.1,2
Such techniques include T2* gradient echo (T2* GRE) and most
sensitively susceptibility-weighted imaging (SWI).3 Since the im-
provements of these tools, microbleeds have been recognized in-
creasingly in various cerebral diseases.
In acute traumatic brain injury, microbleed detection may aid the
diagnosis, severity, and prognosis assessment of hemorrhagic dif-
fuse axonal injury.4–12 Unfortunately, results are heterogeneous,
which detains clinical feasibility.13,14 A potential confounding
factor may be the inconsistent MRI appearance of microbleeds over
time, as a result of the different possible biophysical states of blood.
Such temporal MRI features of large volume bleedings (i.e.,
hematomas) have been characterized widely based on both human
investigations and experimental studies, encompassing hyperacute
to chronic stages.15–23 The T1, T2, and magnetic susceptibility
properties are affected substantially by the form of hemoglobin, the
presence of hemoglobin breakdown products, red blood cell
membrane integrity, or clot formation.15 Because peripheral and
central parts of hematomas are prone to different biochemical
Departments of 1Neurosurgery and 2Radiology, Pe´cs Medical School, Pe´cs, Hungary.
3MTA-PTE Clinical Neuroscience MR Research Group, Pe´cs, Hungary.
4Department of Biochemistry and Medical Chemistry, Pe´cs Medical School, Pe´cs, Hungary.
5Ja´nos Szenta´gothai Research Centre, University of Pe´cs, Pe´cs, Hungary.
6Research Group for Experimental Diagnostic Imaging, Pe´cs Medical School, Pe´cs, Hungary.
7Diagnostic Center of Pe´cs, Pe´cs, Hungary.
 Arnold To´th et al., 2018; Published by Mary Ann Liebert, Inc. This Open Access article is distributed under the terms of the Creative Commons
License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original
work is properly credited.
JOURNAL OF NEUROTRAUMA 36:1670–1677 (May 15, 2019)
Mary Ann Liebert, Inc.
DOI: 10.1089/neu.2018.6004
1670
environments, at certain stages, these hemorrhage compartments
show marked MRI signal differences.15,19,24–26
Based on these studies, however, microbleed MRI dynamics
cannot be understood fully: the size of a microbleed may be indeed
in a microscopic range2,27,28; consequently, the relative surface
(surface area to volume ratio) of a microbleed is vast compared
with macroscopic hemorrhages. Therefore, both the active and
passive biochemical alterations of blood components in a micro-
bleed may differ significantly.
Observations on possible short-term temporal MRI appearance
changes of microbleeds are yet scarce.29 Previously, we reported
human traumatic brain injury case series demonstrating acute to
subacute expansion of traumatic microbleeds in SWI.30 Other case
reports presented that traumatic microbleeds in MRI may become
reduced in number or volume,5 disappear,31 or transiently disap-
pear32 early after injury. In a study focusing on cerebral blood flow
changes in an experimental rat closed head injury model, authors
ancillary reported some cases when hypointense foci congruent
with microbleeds disappeared and later reappeared.33
Based on these case reports, it is uncertain whether acute micro-
bleed appearance changes are because of changes in blood presence
(full degradation for disappearance, re-bleeding/progression for re-
appearance and expansion), or because of change in MR visibility
over time. Therefore, we aimed to develop an experimental micro-
bleed model suitable for the confirmation and characterization of
short-term microbleed MRI appearance alterations. Histological
processing was also performed to examine microbleed presence.
Methods
Rat microbleed model
Nineteen male Sprague Dawley rats weighing 350 g–450 g
(Charles River Laboratories, Wilmington, MA) were used. The an-
imals were maintained on a standard rodent diet with free access to
water. All animals were previously healthy. All of the experiments
and the general handling of the animals were approved by the Na-
tional (Hungarian) Scientific Ethical Committee on Animal Ex-
perimentation (Number of permission: BA02/2000-69/2017 - valid
for five years). All the procedures fully complied with national
and international standards especially with Decree No. 40/2013
(II. 14.) of the Hungarian Government and EU Directive 2010/
63/EU on the protection of animals used for scientific purposes.
Anesthesia was induced in a bell jar for 5 min under 4% iso-
flurane (Forane, Abbott, Abbott Park, IL) and a 7:3 mixture of
N2O/O2, and maintained using isoflurane decreased to 1–3% de-
livered through a nasal mask. Rectal temperature was measured
with a rectal probe (RET-4, Physitemp Instruments, Clifton, NJ)
and thermometer (BAT-12, Physitemp Instruments, Clifton, NJ).
The animal temperature was held at 36–38C using a silicon tube,
shaped to form a cylinder around the animal, connected to a
hot/cold water circulator device (Scanvac heat safe SHC 2000,
Labogene, Lynge, Denmark).
The rat was placed in a laboratory standard stereotactic frame
(Stoelting Co., Wood Dale, IL). A midline scalp incision was made,
and the skull was exposed with blunt dissection. A burr hole was
placed 2 mm lateral to midline, 5 mm posterior to bregma, on both
sides. To elicit microbleed formation, the brain was pierced ver-
tically in a depth of 4 mm from the dura, using a stainless steel
needle (Hamilton, Reno, NV) with a diameter of 159 lm (34 G) on
the right side and 474 lm (26s G) on the left side. No blood or
material was injected. The burr hole was sealed with bone wax, the
wound was closed, and the rat was immediately transferred to the
MR scanner. The entire surgical procedure took approximately
30 min.
MRI
Animals were anesthetized during MRI as well, with 1–3%
isoflurane and a 7:3 mixture of N2O/O2 administered through a nose
cone animal holder. The animal temperature was held at 36–38C
degrees using a digital circulator device (Thermo Scientific Haake
SC100, Waltham, MA). Imaging was performed on a Bruker
(Bruker) 4.7 T Biospec 47/16 scanner with a receive-only 2 · 2
surface array coil for rat brain (Bruker). After obtaining a three-
plane gross scout imaging, high resolution T2 weighted imaging
was performed also in three planes to localize injury sites precisely
(RARE sequence repetition time/echo time [TR/TE] = 2428/
36 msec, RARE factor = 8, echo spacing= 12 msec, number of av-
erages = 2, image matrix = 256 · 256 FOV = 35 · 35 mm2). Pre-
vious to acquiring SWI, map shimming was performed covering the
brain with an ellipsoid volume. The SWI slice volume was adjusted
centered to lesion sites based on the T2 images. The SWI was
performed using the following parameters: three-dimensional (3D)
acquisition type FcFLASH sequence, TR/TE= 29/11 msec, number
of averages= 2, image matrix= 192·192· 48, FOV=32· 32· 8
mm3, flip angle= 12 degrees, mask weighting= 4 with gauss broad=
0.33 mm). Filtered phase data were stored.
As a pilot, three animals underwent imaging at five time points
(immediate, 12 h, 24 h, 48 h, 125 h after injury). Based on the
findings of these images and adhering to scanner availability, three
imaging time points were set as immediate, 24 h, and 125 h for the
further 16 animals. Of these 16 animals, 10 completed the three
time points and were euthanized under anesthesia for histopatho-
logical evaluation. Three animals were euthanized after the im-
mediate, and another three after the 24 h imaging.
MRI data analysis
To visualize hypointense lesions without partial volume effects
or dependence on slice orientation, ParaVision Acquisition 6.0.1
software (Bruker) was used to create coronal plane minimum in-
tensity projection (minIP) images of 0.2 mm thick sections of the
3D SWI volumes. These sections were placed on the site of injury
based on the signs of the skull burr holes and anatomy. The sections
were checked to include all hypointensities related to the injury site.
The minIP images were exported upsampled to a matrix of
768· 768. To visualize 3D filtered phase data, the same steps were
performed except using maximal instead of minimal intensity
projection.
Quantitative analysis of hypointense lesion extent referring to
microbleeds was performed using ImageJ software version 1.51k
(Wayne Rasband, National Institutes of Health).34 A stack was built
from all animals all time point SWI minIP images. First, voxel
hypointensity was defined: in immediate time point minIP images,
a rectangle shaped region of interest (ROI) of 50 voxels width
( = 2.1 mm) and 100 voxels height ( = 4.2 mm) was drawn and fitted
over the normal appearing brain parenchyma (next to but excluding
lesion sites, also excluding large vessels) in all animals (Fig. 1a).
Using such ROIs, histogram analyses were applied to find the
lowest included intensities (Fig. 1d). The average value of these
lowest intensities was found to be 76; therefore, voxels with an
intensity of £75 were defined as hypointense.
This ROI at identical sites and histogram analysis were also
applied to the 24 h and 125 h minIP images to calculate average
intensities. Based on these intensities, 24 h and 125 h image in-
tensities were normalized to the immediate image intensity for each
animal. Then, another rectangle shaped ROI of 50 voxels width
( = 0.2 mm) and 100 voxels height ( = 0.42 mm) was created. This
ROI was placed over the injury sites (Fig. 1b), based on burr holes if
the microbleed not visible, blinded to imaging time points, to ex-
tract the number of hypointense (£ 5) voxels referring to micro-
bleeds (Fig. 1e). Ventricular hemorrhage was included, if present.
Bone was used as a control structure, because bone appears
hypointense in SWI but can be assumed to not undergo any volume
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changes over the 125 h investigation period. Therefore, a control
ROI with identical dimensions as lesion ROI was placed over the
lateral part of the parietal bone at the same level as the injury site
and was rotated perpendicular to the bone (Fig. 1c). The number of
hypointense voxels of the bone under the control ROI was extracted
using the same intensity threshold value of 75 (Fig. 1f).
The number of hypointense voxels over both side lesion sites
(i.e., microbleed extents) and parietal bone (control) across the
immediate, 24 h, and 125 h time points were compared using re-
peated measures analysis of variance (ANOVA) with Bonferroni
correction using Medcalc ver. 13.0.0.0 (MedCalc Software bvba,
Ostend, Belgium).35 Such corrected p value less than 0.05 was
considered statistically significant. Thirteen animals were available
with the necessary three imaging time points for this analysis (the
other six animals of the overall 19 animals were euthanized at
earlier time points).
Histology
After euthanasia, transcardial perfusion was performed with
isotonic saline followed by 4% paraformaldehyde. That was per-
formed in three cases after the immediate MRI acquisition, in an-
other three cases after the 24 h acquisition, and after the 125 h
imaging time point for the rest of the animals. The formalin fixation
of the heads was continued for at least two weeks. Then, the brains
were removed from the skull and were embedded in paraffin. If
lesion sites were visible on the surface of the brain, the surrounding
region was cut into 6lm thick coronal sections and stained using
Prussian blue. When lesion sites were not visible, the coronal
sections were cut from the region supposed to contain lesions based
on anatomy, and only every 10th section was first stained with
Prussian blue to identify sections including the bleedings in the
largest volume. Second, the adjacent sections were also stained to
capture the entire bleeding. Bleedings were defined as extravasated
red blood cells, or hemosiderin reaction at the lesion sites.
Results
Hypointensities referring to microbleeds along both the left and
right brain parenchymal injury sites were present in the immediate
minIP images of all animals (Fig. 2A, 3). According to the lesser
(right side) and greater (left side) gauge injury, the right side hy-
pointensities appeared generally smaller than the left side ones.
Occasionally, small amounts of blood entering the ventricles were
observed. In the first set of animals that underwent five imaging
time points, the hypointensities became smaller or completely ab-
sent in the 12 h, 24 h, and 48 h acquisitions (Fig. 2A). In the 125 h
acquisitions, the hypointensities were again present of similar
shape, extent, and intensity as in the immediate time point. The
further 10 animals that underwent three time point imaging pre-
sented the same temporal characteristics: Hypointensities were
present in the immediate imaging, decreased in extent or com-
pletely disappeared at the 24 h time point, and appeared the same as
in the immediate imaging at the last (125 h) acquisition (Fig. 3).
Complete lesion disappearance occurred in nine of 13 animals at
the lesser gauge injury site, and in five of 13 animals at the larger
gauge injury site. In three animals (second in Fig. 2A, first and ninth
in Fig. 3) at the larger gauge injury track, relatively large hy-
pointensities referring to relatively large (macroscopic) circum-
scribed blood collections were formed showing no noticeable
change over time.
Average hypointensity extents were significantly (corrected
p < 0.05) smaller at the 24 h time point compared with the imme-
diate and the 125 h acquisitions (Fig. 4A, 4B). Repeated measures
ANOVA of the average hypointensity extents of the control parietal
bone region did not show any significant (corrected p< 0.05) dif-
ference among the time points. The results of the ANOVA tests are
presented in Table 1.
FIG. 1. Illustration of the applied regions of interests (ROIs, overlaid on an immediate time point minimal intensity projection image)
and their histograms with dash-dot lined boxes indicating ‘‘hypointense voxel’’ range. (a, d) Normal brain ROI and histogram, used to
define hypointensity: the average value of the lowest intensities over normal brain (including all animals’ immediate time point images,
not only the presented one) was found to be 76; therefore, voxels with an intensity of £75 were defined as hypointense. (b, e) Microbleed
ROI and histogram, used to calculate the number of hypointense voxels at injury sites corresponding to microbleed volumes (applied at
all time points). The presented microbleed ROI included 791 hypointense voxels (see box in histogram). (c, f) Control ROI and
histogram, for calculating the hypointense voxel number (applied at all time points) of the hypointense structure parietal bone assumed
not to undergo volume changes over time. The presented control ROI included 1,202 such hypointense voxels (see box in histogram).
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Filtered phase images presented a similar temporal pattern based
on visual inspection—i.e., pronounced phase alterations in forms of
hyperintensities at lesion sites were present at the immediate and
last imaging (125 h) that were less apparent at the 12 h, 24 h, or 48 h
time points. Figure 2B shows filtered phase images of the three
animals that underwent five imaging time points.
Histology
Bleedings were present in all animals at the lesion sites re-
gardless of the time point of euthanasia. In the vast majority of
cases, bleedings were macroscopically not visible in the slides, and
their diameter (width) was measured to be typically 60–100 lm; at
FIG. 2. (A) Coronal susceptibility-weighted imaging (SWI) minimum intensity projection images of three rats that underwent five
imaging time points (each row represents different animals). Hypointensities along both the left and right side brain parenchymal injury
sites were present in the immediate acquisition. The hypointensities became smaller or completely absent in the 12 h, 24 h, and 48 h
acquisitions. In the 125 h acquisitions, the hypointensities were again present in a similar shape, extent, and intensity as at the immediate
time point. In the second animal, at the larger gauge injury track (left), a relatively large circumscribed blood collection was formed
showing no noticeable change over time. (B) Coronal maximum intensity projection images of the same rats’ filtered phase images.
Hyperintensities consistent with phase alteration at lesion sites are more pronounced at the immediate and 125 h imaging time point than
at the 12 h, 24 h, or 48 h time points.
FIG. 3. Coronal susceptibility-weighted imaging minimum intensity projection images of 10 rats that underwent three imaging time
points (each column represents different animals). Hypointensities along both the left and right side brain parenchymal injury sites were
present in the immediate acquisition. The hypointensities became smaller or completely absent at the 24 h time point and were again present
at the 125 h time point, with a similar shape, extent, and intensity as at the immediate time point. In the first and ninth animals, at the larger
gauge injury track (left), relatively large circumscribed blood collections were formed showing no noticeable change over time.
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a few sites maximal diameters reached 200 lm. The relatively large
circumscribed hypointensities in SWI that were accidentally
formed in three animals (second in Fig. 2A, first and ninth in Fig. 3),
however, were macroscopically visible in both the paraffin tissue
blocks and the slides, measuring 500–900lm diameters. In animals
that were euthanized at 24 h after injury, bleeds were still present as
expected based on the immediate imaging, despite the decrease or
disappearance of corresponding hypointensities at 24 h imaging.
Only by the last (125 h) time point, the presence of hemosiderin was
shown by Prussian blue staining. Corresponding representative
findings are shown in Figure 5.
Discussion
We developed an experimental model in which histologically
proven brain parenchymal microbleeds were produced and reliably
detected by SWI. Microbleeds significantly decreased in extent and
often completely became invisible between the immediate and the
24 h acquisition time point. Until the last (125 h) imaging time
point, a significant re-increase—i.e., re-appearance—was present.
Complete invisibility at 24 h occurred commonly. Histopatholo-
gical findings confirmed that microbleeds did not actually vanish,
because microbleeds were present in all time points of animal
euthanasia. These findings highly explain the observations of pre-
vious human case reports and an experimental case report on mi-
crobleeds appearance changes,5,30–33 and at the same time indicate
that short-term microbleed change is a general phenomenon, be-
cause of MR visibility change over time. In humans, the timing of
the temporary disappearance might be somewhat slower. Based on
the case observations by Watanabe and coworkers,32 microbleed
invisibility might take place roughly between 24 h and seven days
after formation.
Accidentally, larger blood collections resembling hematomas
instead of microbleeds occurred at the injury sites, probably be-
cause of an injury of a relatively large vessel. These hematoma-like
lesions did not disappear or show obvious changes over time. This
implied that the phenomenon of temporary invisibility is dependent
on bleeding size.
The explanation of the phenomenon of temporary microbleed
invisibility is challenging. Based on the macroscopic hemorrhage
literature, a possible reason is the development of methemoglobin
that markedly decreases T1 relaxation time because of dipole-
dipole interactions.15,36 Consequently, T1 shine-through may occur
in SWI or T2* GRE images.18,19,32 In the present study, however,
some arguments can be made against the development of methe-
moglobin as the explanation for microbleed signal void cessation.
First, apparent microbleed signal increase was found as early as
12 h, while methemoglobin is expected to form earliest at 24 h in
rats.18,37 Second, no T1 shine through or hyperintensity was de-
tected over the lesions. Third, phase effects appeared to be di-
minished at 24 h, implying the weakening of paramagnetism. That
is in contrast with the supposed effect of methemoglobin; methe-
moglobin is regarded to be just as paramagnetic as deox-
yhemoglobin, because of its five unpaired electrons.15,36,38
Unlike deoxyhemoglobin, oxyhemoglobin is known to not cause
signal void in SWI; therefore, a theoretical explanation for the
development of microbleed invisibility might be blood oxygena-
tion. The passive oxygenation of microbleeds in the brain, however,
FIG. 4. Average temporal susceptibility-weighted imaging hypointensity extent changes at the injury sites in 13 animals. (A) Left side
(larger gauge injury). (B) right side (lesser gauge injury). Asterisks refer to analysis of variance pairwise comparisons between time
points resulting in a Bonferroni corrected p value of <0.05.
Table 1. Results of Hypointensity Extents Repeated












Extenta Immediate 908 652 1958
24 h 212 64 2134
125 h 716 578 2286
p valueb 24 h vs.
Immediate
< 0.0001 0.0022 1




aNumber of hypointense voxels in the minimum intensity projection images.
bp values from pairwise comparisons, Bonferroni corrected.
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can be excluded, because normal brain tissue O2 tension is known
to be not higher than venous blood O2 tension either in humans or
rats.39,40 In fact, bleedings of even an arterial source should become
and remain deoxygenated.15
Another important mechanism possibly affecting MRI appear-
ance in the hyperacute phase is the increase of red blood cell ratio
because of clot retraction.15,22 An elevation in hematocrit to ap-
proximately 90% occurs when extravasated blood settles and
subsequently forms a retracted clot.41
Some studies presented parabolic correlations between T2 re-
laxation time and deoxygenated red blood cell concentration, so
that shortest T2 times occurred at hematocrits of 50%.23,42 It has
been postulated that local field inhomogeneity in extracellular
water caused by deoxyhemoglobin containing red blood cells re-
sults in selective T2 relaxation enhancement (T2 time decrease).23
If the blood is concentrated by clotting or settling, the removal of
the extracellular water will greatly reduce the effects of T2 proton
relaxation enhancement23,43; that explains T2 time lengthening at
higher hematocrits.
Such hematocrit and local field inhomogeneity dependent T2
relaxation effect is very likely to be linked to the T2* effect as well.
Clot inhomogeneity at voxel level is regarded to cause signal loss in
GRE.21,43 In contrast, full retracted clots despite containing red
blood cells with deoxygenized hemoglobin have been shown to
increase signal in GRE.21 Such samples may paradoxically not
cause a marked signal void in SWI either. This is in contrast with
the findings of Barnes and associates44 who have shown that in vivo
blood sedimentation because of stasis in veins is related to phase
shift and signal decrease in SWI.
In this study, however, the hypointense settled blood fell into
macroscopic range and, lacking microscopic analysis, no infor-
mation could be obtained regarding voxel level inhomogeneity.
Therefore, it still can be postulated that homogeneous clot forma-
tion caused signal gain at the microscopic level might be the
primary reason for the temporary invisibility of microbleeds.
Macroscopic hematomas, in turn, are regarded to be composed of
partial retracted clots with small plasma pools20,21,26,45 maintaining
signal void in susceptibility sensitive MRI probably as a result of
voxel level inhomogeneity.21
The re-appearance of microbleeds from the 24 h to last imaging
time points can be explained by the development of late breakdown
products of hemoglobin as hemosiderin and ferritin, known to be
superparamagnetic.2,15
For the MR investigation of microbleeds, this model had some
advantages compared with other injury and hemorrhage models, such
as the weight drop/fluid percussion trauma models,46,47 or autologous
blood, collagenase injection,48 and lipopolysaccharide49 hemorrhage
models. Instead of macroscopic hematomas, our model produced
true microbleeds, in controlled locations, without unnecessary bur-
dening of the animals—none of the animals were lost or showed any
signs of significant morbidity during the examination period.
Still, this study has certain limitations. Because we performed
the examination using single hardware and set of parameters, it
cannot be excluded that changes in specific parameters would affect
the characteristics of this phenomenon. At the same time, the fact
that different, 1.5 T and 3 T systems were applied in previous
human case reports leading to comparable findings30,33 strongly
suggests that the phenomenon is not scanner dependent. The mech-
anism of microbleed formation because of direct vessel injury in the
present model is obviously different from the expected more in-
direct vessel injury mechanisms in traumatic brain injury. The
actual circumstances of microbleed formation, however, are very
FIG. 5. Correlations of susceptibility-weighted imaging (SWI) and histology of microbleeds. First, second, and third lines show rats
that were euthanized after the immediate, 24 h, or 125 h imaging, respectively. The available coronal SWI minimum intensity projection
images of microbleeds of interest are presented, with inserts indicating the corresponding histological (Prussian blue staining, 70x and
800x) images. Blood products are apparent in the animal euthanized at 24 h and 125 h as well, despite the absence of hypointensities in
the 24 h SWIs. Prussian blue staining indicates the presence of hemosiderin at 125 h.
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unlikely to substantially influence the later biochemical sequelae of
the extravasated blood products.
The phenomenon of short-term temporary microbleed visibility
decrease in MRI may have direct clinical and scientific implica-
tions. An inadequate timing of MRI for detecting microbleeds may
result in false negative findings. In follow-up imaging, microbleed
disappearance should not be interpreted as real regression, while
appearance should not be misdiagnosed as re-bleeding or hemor-
rhagic transformation. The latter, however, cannot be certainly
excluded when missing hyperacute imaging. The detection of both
the disappearance and re-appearance of a microbleed may be the
only way to differentiate new microbleeds from chronic ones.
Conclusion
We developed a reliable experimental model for temporal mi-
crobleed MRI examinations and confirmed general temporary re-
duction in visibility of microbleeds in the acute phase in SWI.
Although the exact explanation of this phenomenon remains elu-
sive, our findings prove that imaging timing is important when
using SWI acutely as a diagnostic tool for microbleeds.
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